MedTrace Logo

PEEK Versus Silicon Interspinous Spacer for Reduction of Supradjacent Segment Degeneration

NCT03477955 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2018-04-10

No results posted yet for this study

Summary

A retrospective study that aims to report Adjacent Segment Degeneration (ASD) incidence and spinopelvic balance in short lumbosacral instrumentation for degenerative lumbar spinal stenosis. Although ASD is a common complication following lumbar fusion, the effect of an Interspinous Spacer (IS) in the supradjacent segment in short lumbosacral instrumented fusion and its interaction with spinopelvic balance has not been studied adequately.

Conditions

  • Adjacent Segment Degeneration

Interventions

PROCEDURE

PEEK interspinous spacer

To study the Adjacent Segment Degeneration incidence in the supradjacent segment following short lumbar fusion between PEEK and Silicon Interspinous spacers.

Sponsors & Collaborators

  • St. Andrew's General Hospital, Patras, Greece

    collaborator OTHER

  • University Hospital of Patras

    lead OTHER

Principal Investigators

  • Panagiotis Korovessis, PhD · General Hospital of Patras

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
49 Years
Max Age
71 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2006-04-30
Completion
2009-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03477955 on ClinicalTrials.gov